Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04552834 · ClinicalTrials.gov registry record

Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes

A clinical trial of Critical Illness and Microbiome, sponsored by University of Chicago.

Active
Registry status
500
Enrollment target
1
Study location

NCT04552834 is a study of Critical Illness and Microbiome that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 500 participants, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04552834, a study of Critical Illness and Microbiome, is active but no longer recruiting, sponsored by University of Chicago.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

This study is designed to study the variations in the microbiome among critically ill patients and the effect of admission to the medical intensive care unit (MICU) at the University of Chicago. Additionally, investigators will examine the downstream clinical effects of dysbiosis in ICU patients and how patients maybe effected long term.

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2020-09-15
Est. Completion 2026-06-01

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT04552834

The ClinicalTrials.gov registry entry for NCT04552834 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,133-participant average among 91 other Critical Illness trials with a reported enrollment target (84% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 0 interventions.

NCT04552834 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04552834 about?

NCT04552834 is a clinical study titled "Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes". This study is designed to study the variations in the microbiome among critically ill patients and the effect of admission to the medical intensive care unit (MICU) at the University of Chicago. Additionally, investigators will examine the downstream clinical effects of dysbiosis in ICU patients and...

What is the current status of trial NCT04552834?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2020-09-15. Estimated completion is 2026-06-01.

What conditions does trial NCT04552834 study?

This clinical trial studies the following conditions: Critical Illness, Microbiome.

Who is sponsoring clinical trial NCT04552834?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04552834 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.